{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:00:10Z","timestamp":1783119610184,"version":"3.54.6"},"reference-count":17,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Lab Hematology"],"published-print":{"date-parts":[[2018,12]]},"abstract":"Abstract<\/jats:title>Introduction<\/jats:title>CD<\/jats:styled-content>13 is a myeloid associated antigen, which may be expressed by a subset of B cell lymphomas; however, the significance of its expression along with other B cell associated antigens is not well characterized.<\/jats:p><\/jats:sec>Methods<\/jats:title>Two hundred and eighty\u2010six mature B cell neoplasms with flow cytometric analysis performed at the time of diagnosis were identified. Expression of CD<\/jats:styled-content>13, CD<\/jats:styled-content>45, CD<\/jats:styled-content>19, CD<\/jats:styled-content>20, CD<\/jats:styled-content>5, CD<\/jats:styled-content>10, CD<\/jats:styled-content>38, CD<\/jats:styled-content>22, CD<\/jats:styled-content>23, FMC<\/jats:styled-content>7, and kappa and lambda light chains was assessed for each case and correlated with clinicopathologic features.<\/jats:p><\/jats:sec>Results<\/jats:title>CD<\/jats:styled-content>13 expression was associated specifically with cases of lymphoplasmacytic lymphoma (LPL<\/jats:styled-content>) (16\/26)\u2010 and FMC<\/jats:styled-content>7\u2010positive chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL<\/jats:styled-content>\/SLL<\/jats:styled-content>) (11\/30). No cases of follicular lymphoma (FL<\/jats:styled-content>) expressed CD<\/jats:styled-content>13 (0\/48). Across all B cell neoplasms, CD<\/jats:styled-content>13 expression positively correlated with FMC<\/jats:styled-content>7 co\u2010expression and kappa light chain restriction and negatively correlated with CD<\/jats:styled-content>10 co\u2010expression and lambda light chain restriction. No significant association of CD<\/jats:styled-content>13 with overall or disease free survival in B cell neoplasms was seen.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>CD<\/jats:styled-content>13 expression is present more often in LPL<\/jats:styled-content>\u2010 and FMC<\/jats:styled-content>7\u2010positive CLL<\/jats:styled-content>\/SLL<\/jats:styled-content> than other mature B cell lymphoma subtypes and absent in cases of FL<\/jats:styled-content> and may be a useful feature for diagnostic subtyping.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ijlh.12909","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T12:47:08Z","timestamp":1533127628000},"page":"715-720","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["An integrated flow cytometry analysis of 286 mature B cell neoplasms identifies CD<\/scp>13 as a useful marker for diagnostic subtyping"],"prefix":"10.1111","volume":"40","author":[{"given":"Hubert","family":"Lau","sequence":"first","affiliation":[{"name":"Stanford University Medical Center Stanford California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Nagy","sequence":"additional","affiliation":[{"name":"Stanford University Medical Center Stanford California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Atwater","sequence":"additional","affiliation":[{"name":"Stanford University Medical Center Stanford California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5537-7740","authenticated-orcid":false,"given":"Michael J.","family":"Cascio","sequence":"additional","affiliation":[{"name":"Oregon Health Sciences University Portland Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-3440","authenticated-orcid":false,"given":"Robert S.","family":"Ohgami","sequence":"additional","affiliation":[{"name":"Stanford University Medical Center Stanford California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2016.07.008"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-009-0731-6"},{"issue":"2","key":"e_1_2_6_4_1","first-page":"1","article-title":"Selective immunophenotyping for diagnosis of B\u2010cell neoplasms: immunohistochemistry and flow cytometry strategies and results scott","volume":"21","author":"Boyd SD","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2006.02369.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20485"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12594"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0506-500"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPV8LN5ENMZOVY"},{"issue":"2","key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1182\/blood.V75.2.462.462","article-title":"Metalloprotease activity of CD13\/aminopeptidase N on the surface of human myeloid cells","volume":"75","author":"Ashmun RA","year":"1990","journal-title":"Blood"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/2.suppl_2.107"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1309\/FNGCYEMJE3MAE5L2"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.11.019"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1309\/T88X-71U4-WC0R-2531"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-624288"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-4024"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64159-4"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijlh.12909","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.12909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T09:29:50Z","timestamp":1694770190000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.12909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1111\/ijlh.12909"],"URL":"https:\/\/doi.org\/10.1111\/ijlh.12909","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"value":"1751-5521","type":"print"},{"value":"1751-553X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"assertion":[{"value":"2018-01-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}